Evidence map›Paper›PMID 24210352›Full record

ArticleImmunity2013

A beneficial role for immunoglobulin E in host defense against honeybee venom.

Thomas Marichal, Philipp Starkl, Laurent L Reber, Janet Kalesnikoff, Hans C Oettgen, Mindy Tsai, Martin Metz, Stephen J Galli

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 181 citations in OpenAlex.

  1. Review
  2. Developments in Mast Cell Research.The Journal of allergy and clinical immunology · 2026
    Review
  3. Review
  4. Article
  5. Skin-Derived PGDAllergy · 2025
    Article
  6. Article
  7. Review
  8. Neuroimmune Circuits in Allergic Diseases.Annual review of immunology · 2025
    Review
  9. Review
  10. Progressively differentiated TNature immunology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.International journal of molecular sciences · 2024
    Review
  16. Mast cells: a double-edged sword in inflammation and fibrosis.Frontiers in cell and developmental biology · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thomas MarichalDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Philipp Starkl
Laurent L Reber
Janet Kalesnikoff
Hans C Oettgen
Mindy Tsai
Martin Metz
Stephen J Galli
Stanford University · USBoston Children's Hospital · USCharité - Universitätsmedizin Berlin · DE

Funding

Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Role of Mast Cells in Inflammation and ImmunityR01CA072074 · NCI · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1996 to 2010
$4.4M
Expression and Modulation of Mast Cell Function in AsthmaR01AI070813 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2006 to 2010
$2.5M
Regulation of Mast Cell Development and FunctionR01AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1986 to 2010
$2.4M
REGULATION OF MAST CELL DEVELOPMENT &FUNCTIONR37AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN J · 1996 to 2005
$2.2M
Austrian Science Fund FWF J 3399NCATS NIH HHS UL1 TR001085NCI NIH HHS CA072074NCI NIH HHS R01 CA072074NCRR NIH HHS UL1 RR025744NIAID NIH HHS AI023990NIAID NIH HHS AI070813NIAID NIH HHS R01 AI023990NIAID NIH HHS R01 AI070813NIAID NIH HHS R37 AI023990
6 · The paper itself

Abstract

Allergies are widely considered to be misdirected type 2 immune responses, in which immunoglobulin E (IgE) antibodies are produced against any of a broad range of seemingly harmless antigens. However, components of insect venoms also can sensitize individuals to develop severe IgE-associated allergic reactions, including fatal anaphylaxis, upon subsequent venom exposure. We found that mice injected with amounts of honeybee venom similar to that which could be delivered in one or two stings developed a specific type 2 immune response that increased their resistance to subsequent challenge with potentially lethal amounts of the venom. Our data indicate that IgE antibodies and the high affinity IgE receptor, FcεRI, were essential for such acquired resistance to honeybee venom. The evidence that IgE-dependent immune responses against venom can enhance survival in mice supports the hypothesis that IgE, which also contributes to allergic disorders, has an important function in protection of the host against noxious substances.

Indexed as

AnaphylaxisAnimalsBee VenomsDaboiaDesensitization, ImmunologicDose-Response Relationship, ImmunologicEpitopesFemaleHypersensitivityImmunization, PassiveImmunoglobulin EImmunoglobulin GMast CellsMiceMice, Inbred BALB CMice, Inbred C57BLBee VenomsEpitopesImmunoglobulin EImmunoglobulin GReceptors, IgEViper Venoms

Identifiers

PMID24210352
PMCPMC4164235
OpenAlexW2087581254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.